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Cobras	 (Naja	 spp.)	 are	 some	of	 the	most	 venomous	 and	 dangerous	 snakes	worldwide,	 responsible	 for	 high	
mortality	 and	 morbidity.	 The	 most	 toxic	 components	 of	 cobra	 venoms	 are	 cobratoxins,	 which	 target	 the	
nicotinic	 acetylcholine	 receptors	 (nAChRs)	 responsible	 for	neuromuscular	 transmission.	 Inhibition	of	nAChRs	
may	 lead	to	respiratory	arrest	with	death	as	a	result	within	3-12	hr	after	a	bite	 from	a	cobra.	Early	parental	
administration	of	appropriate	antivenom	is	the	cornerstone	of	life	saving	snakebite	therapy.	However,	current	
antivenoms	 are	 still	 produced	 by	 animal	 immunization,	which	 is	 a	 laborious	 and	 expensive	 process	 yielding	
highly	 immunogenic	 antivenoms	 due	 to	 the	 heterologous	 nature	 of	 equine	 antibodies	 in	 the	 antivenom.	 In	









Currently,	 we	 are	 working	 in	 an	 approach	 for	 optimizing	 the	 peptide	 lead	 by	 designing	 and	 characterizing	
improved	 analogues.	 The	 poster	 will	 include	 the	 methodology	 and	 results	 of	 optimized	 peptide	 leads	 to	
include	in	promising	peptide-based	antitoxins.	
	
This	may	pave	the	way	 for	 treating	 the	clinical	manifestations	of	neurotoxic	envenomings	caused	by	 long	α-
neurotoxins,	thus	providing	protection	against	many	cobra	species.	
	
	
